Related Experiment Video
Updated: Dec 8, 2025

A Model to Simulate Clinically Relevant Hypoxia in Humans
Published on: December 22, 2016
Caffeine versus aminophylline in combination with oxygen therapy for apnea of prematurity: A retrospective cohort
Cheng-Yun Zhang1, Dong-Jie Liu1, Shao-Dong Hua2
1Department of Neonatology, The First People's Hospital of Zhengzhou City, Zhengzhou, Henan 450000, P.R. China.
Insights
Caffeine citrate is more effective than aminophylline for treating apnea in premature infants. Caffeine reduces oxygen needs and complications, improving treatment outcomes.
Area of Science:
- Neonatal Medicine
- Pharmacology
- Respiratory Medicine
Background:
- Apnea is common in premature infants, requiring interventions like oxygen therapy.
- Caffeine and aminophylline are used to manage apnea, but their comparative efficacy varies.
- Optimizing oxygen delivery is crucial for treating neonatal apnea.
Purpose of the Study:
- To compare the clinical significance of caffeine citrate and aminophylline in treating apnea in premature infants.
- To evaluate the impact of these treatments on oxygen delivery requirements and complications.
- To determine the superior therapeutic agent for neonatal apnea under different oxygenation conditions.
Main Methods:
- Retrospective analysis of clinical data from 120 premature infants with apnea.
- Infants received either caffeine citrate (20 mg/kg/day) or aminophylline (10 mg/kg/day).
- Outcomes assessed included recurrent apnea risk, changes in oxygen duration/concentration, and complication incidence.
Main Results:
- Caffeine treatment significantly reduced oxygen inhalation duration and concentration compared to aminophylline (P<0.05).
- Caffeine also decreased recurrent apnea events and complications (P<0.05 or P<0.01).
- These benefits were observed across varying oxygen delivery conditions, including mechanical ventilation.
Conclusions:
- Caffeine citrate demonstrates superior therapeutic performance over aminophylline for premature infant apnea.
- Caffeine improves supplemental oxygen efficacy and reduces complication rates.
- Caffeine is a preferred agent for managing neonatal apnea, optimizing respiratory support.
Abstract:
The present study was conducted to investigate the clinical significance of caffeine and aminophylline in the treatment of premature infants with apnea under varying conditions of oxygen (O2) delivery. The clinical data of 120 premature infants with apnea treated with oxygen therapy and either caffeine citrate (20 mg/kg/day; n=77) or aminophylline (10 mg/kg/day; n=43) were retrospectively examined. The therapeutic performance of the drugs after the completion of the treatment was evaluated primarily according to the risk of recurrent episodes of apnea, the changes in the duration and concentration of inhaled O2 and the incidence of complications. In contrast to aminophylline, caffeine treatment significantly reduced the duration of O2 inhalation and the inhaled O2 concentration in the infants treated with mechanical ventilation or O2 delivery devices (P<0.05). Treatment with caffeine also decreased the incidence of recurrent apnea events and complications in the investigated population (P<0.05 or P<0.01). Caffeine performs better than aminophylline in the treatment of premature infants with apnea under different conditions of O2 delivery. The therapeutic performance of caffeine is achieved primarily via improving the efficacy of supplemental O2 and reducing the incidence of complications.
Related Concept Videos
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Respiratory Assessment: Purpose and Indications
Objectives and Importance:
The primary goal of respiratory assessment is to evaluate patients at early risk of clinical deterioration. Since respiratory distress often precedes other signs of declining health, breathing patterns and sounds become a...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Cardiopulmonary Resuscitation II: ACLS Airway Management

